Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Keating

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
VO<sub>2max</sub> as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trialJohn Wilson, Xiaojun You, Matt Ellis, et al.
ERJ Open Research|February 11, 2021
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosisSusannah J King, Dominic Keating, Elyssa Williams, et al.
Frontiers in Oncology|April 6, 2026
Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulinThi Thao Vi Luong, Lindon Lin, John Coutsouvelis, et al.
The Annals of Thoracic Surgery|May 4, 2012
Cadaveric lobar lung transplantation: technical aspectsSilvana F Marasco, Stephanie Than, Dominic Keating, et al.
Internal Medicine Journal|August 1, 2024
Current surgical management of chronic thromboembolic pulmonary diseaseHayley Barnes, Daniel Niewodowski, Atsuo Doi, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2013
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipientsSiow-Chin Heng, Gregory I Snell, Bronwyn Levvey, et al.
ERJ Open Research|September 22, 2021
The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosisBrenda M Button, Lisa M Wilson, Angela T Burge, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Heart, Lung & Circulation|October 15, 2017
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New ZealandGeoff Strange, Edmund M Lau, Eleni Giannoulatou, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2020
VO<sub>2max</sub> as an exercise tolerance endpoint in people with cystic fibrosis: Lessons from a lumacaftor/ivacaftor trialJohn Wilson, Xiaojun You, Matt Ellis, et al.
ERJ Open Research|February 11, 2021
Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosisSusannah J King, Dominic Keating, Elyssa Williams, et al.
Frontiers in Oncology|April 6, 2026
Case Report: Successful treatment of steroid-refractory severe immunotherapy-induced pneumonitis with equine antithymocyte globulinThi Thao Vi Luong, Lindon Lin, John Coutsouvelis, et al.
The Annals of Thoracic Surgery|May 4, 2012
Cadaveric lobar lung transplantation: technical aspectsSilvana F Marasco, Stephanie Than, Dominic Keating, et al.
Internal Medicine Journal|August 1, 2024
Current surgical management of chronic thromboembolic pulmonary diseaseHayley Barnes, Daniel Niewodowski, Atsuo Doi, et al.
Antimicrobial Agents and Chemotherapy|July 3, 2013
Relationship between trough plasma and epithelial lining fluid concentrations of voriconazole in lung transplant recipientsSiow-Chin Heng, Gregory I Snell, Bronwyn Levvey, et al.
ERJ Open Research|September 22, 2021
The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosisBrenda M Button, Lisa M Wilson, Angela T Burge, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Heart, Lung & Circulation|October 15, 2017
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New ZealandGeoff Strange, Edmund M Lau, Eleni Giannoulatou, et al.
Pageof 3